Improving lives through computational molecular design

BOSTON, OpenEye miniCUP—Sept. 25, 2025—Cadence Molecular Sciences (OpenEye), a business unit of Cadence (Nasdaq: CDNS), announced today at miniCUP Boston, the launch of ROCS X, an AI-enabled virtual screening solution that allows scientists to conduct 3D searches of trillions of drug-like molecules.

Webinar: Modular Molecular Modeling Join our February miniWebinar led by Paul Hawkins, Product Evangelist. About this session: This webinar will provide an overview of our software libraries or toolkits, with an emphasis on how they can be used to efficiently develop customized, integrated solutions to complex problems in modern drug discovery. We will highlight several examples of the impact our toolkits have in solving a wide variety of problems for our users, including work from PubChem, Pfizer, and AstraZeneca. We will also illustrate the central place that they play in developing our own solutions.